MedTrace Logo

Oral Melatonin as Premedication During MAC for Patients Undergoing Loco-regional Chronic Subdural Hematoma Evacuation

NCT03732963 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-11-27

No results posted yet for this study

Summary

investigators assume that administration of preoperative melatonin will reduce the required dose of propofol in participants undergoing loco-regional chronic subdural hematoma evacuation, it may as well provide better postoperative analgesia and decrease the incidence of delirium.

Conditions

  • Monitored Anaesthesia Care
  • Loco-regional Chronic Subdural Hematoma Evacuation

Interventions

DRUG

Placebo (Group P)

Group P: 20 patients will receive a placebo tablet preoperatively.

DRUG

Melatonin (Group M)

Group M: 20 patients will receive an oral melatonin tablet 10 mg preoperatively.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Abdalla Mohamed, M.D · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-05
Primary Completion
2018-11-05
Completion
2018-11-07

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03732963 on ClinicalTrials.gov